Role of coagulation pathways and treatment with activated protein C in hyperoxic lung injury

Thorax

Volumn 64, Issue 2, 2009, Pages 114-120

  Looney, M R ^a,b   Esmon, C T ^a,b,c   Matthay, M A ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ALBUMIN I 125; BLEOMYCIN; CYCLIC AMP; DROTRECOGIN; OXYGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOMODULIN; ANTICOAGULANT AGENT; PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUID BALANCE; GRAVIMETRY; HYPEROXIA; LUNG ALVEOLUS; LUNG BLOOD VESSEL; LUNG EXTRAVASCULAR FLUID; LUNG INJURY; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; ACUTE LUNG INJURY; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; ELECTROLYTE BALANCE; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY;

ACUTE LUNG INJURY; ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; BRONCHOALVEOLAR LAVAGE FLUID; HYPEROXIA; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; PROTEIN C; THROMBIN; WATER-ELECTROLYTE BALANCE;

EID: 60549088133     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.099135     Document Type: Article

References (35)

1. ARDS Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342:1301-8.
2. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006;354:2564-75.
3. Cepkova M, Matthay MA. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med 2006;21:119-43.
4. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
5. Looney MR, Matthay MA. Bench-to-bedside review: the role of activated protein C in maintaining endothelial tight junction function and its relationship to organ injury. Crit Care 2006;10:239.
6. Bertozzi P, Astedt B, Zenzius L, et al. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 1990;322:890-7.
7. Idell S, James KK, Levin EG, et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989;84:695-705.
8. Wang L, Bastarache JA, Wickersham N, et al. Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation. Am J Respir Cell Mol Biol 2007;36:497-503.
9. Ware LB, Fang X, Matthay MA Protein C and thrombomodulin in human acute lung injury. Am J Physiol Lung Cell Mol Physiol 2003;285:L514-21.
10. Prabhakaran P, Ware LB, White KE, et al. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol 2003;285:L20-8.
11. Perkowski S, Sun J, Singhal S, et al. Gene expression profiling of the early pulmonary response to hyperoxia in mice. Am J Respir Cell Mol Biol 2003;28:682-96.
12. Barazzone C, Belin D, Piguet PF, et al. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J Clin Invest 1996;98:2666-73.
13. Frank JA, Gutierrez JA, Jones KD, et al. Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. Am J Respir Crit Care Med 2002;165:242-9.
14. Looney MR, Sartori C, Chakraborty S, et al. Decreased expression of both the alpha1- and alpha2-subunits of the Na-K-ATPase reduces maximal alveolar epithelial fluid clearance. Am J Physiol Lung Cell Mol Physiol 2005;289:L104-10.
15. Looney MR, Su X, Van Ziffle JA, et al. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 2006;116:1615-23.
16. Li W, Zheng X, Gu J, et al. Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin. J Thromb Haemost 2005;3:1351-9.
17. Gu JM, Katsuura Y, Ferrell GL, et al. Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo. Blood 2000;95:1687-93.
18. Su X, Looney M, Robriquet L, et al. Direct visual instillation as a method for efficient delivery of fluid into the distal airspaces of anesthetized mice. Exp Lung Res 2004;30:479-93.
19. Yasui H, Gabazza EC, Tamaki S, et al. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med 2001;163:1660-8.
20. Faust SN, Levin M, Harrison OB, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001;345:408-16.
21. Finigan JH, Dudek SM, Singleton PA, et al. Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J Biol Chem 2005;280:17286-93.
22. Feistritzer C, Riewald M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 2005;105:3178-84.
23. Kerschen EJ, Fernandez JA, Cooley BC, et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med 2007;204:2439-48.
24. Joyce DE, Gelbert L, Ciaccia A, et al. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 2001;276:11199-203.
25. Cheng T, Liu D, Griffin JH, et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 2003;9:338-42.
26. Tateda K, Deng JC, Moore TA, et al. Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis. J Immunol 2003;170:4209-16.
27. Ware LB, Matthay MA, Parsons PE, et al. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007;35:1821-8.
28. Corne J, Chupp G, Lee CG, et al. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. JClinInvest 2000;106:783-91.
29. Paine R 3rd, Wilcoxen SE, Morris SB, et al. Transgenic overexpression of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxic lung injury. Am J Pathol 2003;163:2397-406.
30. Panos RJ, Bak PM, Simonet WS, et al. Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J Clin Invest 1995;96:2026-33.
31. Siner JM, Jiang G, Cohen ZI, et al. VEGF-induced heme oxygenase-1 confers cytoprotection from lethal hyperoxia in vivo. Faseb J 2007;21:1422-32.
32. Factor P, Dumasius V, Saldias F, et al. Adenovirus-mediated transfer of an Na+/K+- ATPase beta1 subunit gene improves alveolar fluid clearance and survival in hyperoxic rats. Hum Gene Ther 2000;11:2231-12.
33. Robriquet L, Collet F, Tournoys A, et al. Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response. Respir Res 2006;7:41.
34. Liu KD, Levitt J, Zhuo H, et al. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 2008 (Epub ahead of print).
35. Bhandari V, Choo-Wing R, Lee CG, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006;12:1286-93.